Skip to main content
Literatur
1.
Zurück zum Zitat Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L et al (2016) Baricitinib in patients with refractory rheumatoid arthritis. N Engl J Med 374:1243–1252CrossRef Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L et al (2016) Baricitinib in patients with refractory rheumatoid arthritis. N Engl J Med 374:1243–1252CrossRef
2.
Zurück zum Zitat Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. (2020) Baricitinib plus remdesivir for hospitalized adults with covid-19. N Engl J Med [Internet] 2020 [cited 2021 Jul 4]; Available from: https://www.nejm.org/doi/https://doi.org/10.1056/NEJMoa2031994 Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. (2020) Baricitinib plus remdesivir for hospitalized adults with covid-19. N Engl J Med [Internet] 2020 [cited 2021 Jul 4]; Available from: https://​www.​nejm.​org/​doi/​https://​doi.​org/​10.​1056/​NEJMoa2031994
3.
Zurück zum Zitat Holtzman NG, Im A, Ostojic A, Curtis LM, Parsons-Wandell L, Nashed J et al (2020) Efficacy and safety of baricitinib in refractory chronic graft-versus-host disease (cGVHD): preliminary analysis results of a phase 1/2 study. Blood 136:1–1CrossRef Holtzman NG, Im A, Ostojic A, Curtis LM, Parsons-Wandell L, Nashed J et al (2020) Efficacy and safety of baricitinib in refractory chronic graft-versus-host disease (cGVHD): preliminary analysis results of a phase 1/2 study. Blood 136:1–1CrossRef
4.
Zurück zum Zitat Lu X, Tang LV, Wang H-F, You Y, Wang Y-D, Hu Y et al (2021) The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19. Bone Marrow Transplant 56:696–700CrossRef Lu X, Tang LV, Wang H-F, You Y, Wang Y-D, Hu Y et al (2021) The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19. Bone Marrow Transplant 56:696–700CrossRef
Metadaten
Titel
Baricitinib: Two Birds with One Stone
Publikationsdatum
24.01.2022
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2022
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-022-01521-5

Weitere Artikel der Ausgabe 3/2022

Indian Journal of Hematology and Blood Transfusion 3/2022 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.